Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation

American Journal of Transplantation

Volumn 12, Issue 4, 2012, Pages 877-887

  Van Der Pol, P ^a   Schlagwein, N ^a   Van Gijlswijk, D J ^a   Berger, S P ^b   Roos, A ^a   Bajema, I M ^a   De Boer, H C ^a,c   De Fijter, J W ^a   Stahl, G L ^d   Daha, M R ^a   Van Kooten, C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Einthoven Laboratory for Experimental Vascular Biology   (Netherlands)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Complement; Ischemia reperfusion; Kidney transplantation; MBL; Tubular injury

Indexed keywords

CXCL3 CHEMOKINE; MANNAN BINDING LECTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL VIABILITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; HISTOLOGY; IN VITRO STUDY; INTERNALIZATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; LEUKOCYTE; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; CELL DEATH; CELLS, CULTURED; COMPLEMENT ACTIVATION; FLOW CYTOMETRY; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TUBULES; MALE; MANNOSE-BINDING LECTIN; RATS; RATS, INBRED LEW; RENAL INSUFFICIENCY; REPERFUSION INJURY;

EID: 84859322295     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03887.x     Document Type: Article

References (33)

1. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 2007; 357: 797-805.
2. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol 2009; 130: 41-50.
3. Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 2011; 7: 189-200.
4. Pagtalunan ME, Olson JL, Tilney NL, Meyer TW. Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol 1999; 10: 366-373. (Pubitemid 29068077)
5. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827. (Pubitemid 39488068)
6. Zhou W, Farrar CA, Abe K et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000; 105: 1363-1371. (Pubitemid 30322402)
7. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 2003; 170: 1517-1523. (Pubitemid 36139523)
8. Thurman JM. Triggers of inflammation after renal ischemia/ reperfusion. Clin Immunol 2007; 123: 7-13. (Pubitemid 46401502)
9. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: A key system for immune surveillance and homeostasis. Nat Immunol 2010; 11: 785-797.
10. Berger SP, Roos A, MallatMJ, Fujita T, de Fijter JW, Daha MR. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005; 5: 1361-1366. (Pubitemid 40839426)
11. Berger SP, Roos A, Mallat MJ, et al. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2007; 18: 2416-2422. (Pubitemid 47203858)
12. Drickamer K, Dordal MS, Reynolds L. Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein. J Biol Chem 1986; 261: 6878-6887. (Pubitemid 17219457)
13. Jordan JE, Montalto MC, Stahl GL. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 2001; 104: 1413-1418. (Pubitemid 32880155)
14. Castellano G, Melchiorre R, Loverre A, et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion- induced renal damage. Am J Pathol 2010; 176: 1648-1659.
15. Ricklin D, Lambris JD. Complement-targeted therapeutics. Nat Biotechnol 2007; 25: 1265-1275. (Pubitemid 350089828)
16. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL. Myocardial infarction and apoptosis aftermyocardial ischemia and reperfusion: Role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 1998; 97: 2259-2267. (Pubitemid 28265388)
17. Roos A, Bouwman LH, Munoz, J, et al. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 2003; 39: 655-668.
18. Roos A, Nauta AJ, Broers D, et al. Specific inhibition of the classical complement pathway by C1q-binding peptides. J Immunol 2001; 167: 7052-7059. (Pubitemid 33144201)
19. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok- Storb B. HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994; 45: 48-57. (Pubitemid 24045991)
20. van der Pol P, Roos A, Berger SP, Daha MR, van KC. Natural IgM antibodies are involved in the activation of complement by hypoxic human tubular cells. Am J Physiol Renal Physiol 2011; 300: F932-F940.
21. van Kooten C, Gerritsma JS, Paape ME, van Es LA, Banchereau J, Daha MR. Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 1997; 51: 711-721. (Pubitemid 27157955)
22. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification bymorphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756.
23. de Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, BuurmanWA. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: Inhibition of late apoptosis and inflammation. Transplantation 2003; 75: 375-382.
24. Park P, Haas M, Cunningham PN, et al. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion. J Am Soc Nephrol 2001; 12: 1383-1390. (Pubitemid 32666321)
25. Stein JH, Osgood RW, Barnes JL, Reineck HJ, Pinckard RN, Mc- Manus LM. The role of complement in the pathogenesis of postischemic acute renal failure.Miner Electrolyte Metab 1985; 11: 256-261. (Pubitemid 15001514)
26. Brauer RB, Baldwin WM, III, Daha MR, Pruitt SK, Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 1993; 151: 7240-7248. (Pubitemid 24001099)
27. Moller-Kristensen M, Wang W, Ruseva M, et al. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 2005; 61: 426-434.
28. de Vries B,Walter SJ, Peutz-Kootstra CJ,Wolfs TG, van Heurn LW, Buurman WA. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 2004; 165: 1677-1688.
29. Hirano M, Ma BY, Kawasaki N et al. Mannan-binding protein blocks the activation of metalloproteases meprin alpha and beta. J Immunol 2005; 175: 3177-3185. (Pubitemid 41170539)
30. Hirano M, Ma BY, Kawasaki N, Oka S, Kawasaki T. Role of interaction of mannan-binding protein with meprins at the initial step of complement activation in ischemia/reperfusion injury to mouse kidney. Glycobiology 2011; [Epub ahead of print].
31. Matthijsen RA, Derikx JP, Steffensen R, van Dam RM, Dejong CH, Buurman WA. Mannose-binding lectin null alleles are associated with preserved epithelial cell integrity following intestinal ischemia reperfusion in man. Mol Immunol 2009; 46: 2244-2248.
32. Ma Y, Uemura K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: Mannan-binding proteindependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 1999; 96: 371-375. (Pubitemid 29061215)
33. Nonaka M, Ma BY, Ohtani M, et al. Subcellular localization and physiological significance of intracellular mannan-binding protein. J Biol Chem 2007; 282: 17908-17920. (Pubitemid 47100299)